CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）
Clinical trial NCT03544021 · UNKNOWN
Trial details
- NCT number
- NCT03544021
- Sponsor
- The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2019-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.